{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:56:58Z","timestamp":1761155818439},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T00:00:00Z","timestamp":1402099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10067-014-2700-5","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T09:34:23Z","timestamp":1402047263000},"page":"1135-1138","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survival of disease-modifying antirheumatic drugs used as the first antirheumatic medication in the treatment of ankylosing spondylitis in Finland. A nationwide population-based register study"],"prefix":"10.1007","volume":"33","author":[{"given":"Heikki","family":"Relas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Kautiainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Puolakka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri J.","family":"Virta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjatta","family":"Leirisalo-Repo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,7]]},"reference":[{"key":"2700_CR1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ncprheum0297","volume":"2","author":"A Boonen","year":"2006","unstructured":"Boonen A (2006) A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis. Nat Clin Pract Rheumatol 2:546\u2013553","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2700_CR2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/keq131","volume":"49","author":"SM Verstappen","year":"2010","unstructured":"Verstappen SM, Watson KD, Lunt M et al (2010) Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 49:1570\u20131577","journal-title":"Rheumatology (Oxford)"},{"key":"2700_CR3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","volume":"65","author":"J Zochling","year":"2006","unstructured":"Zochling J, van der Heijde D, Burgos-Vargas R et al (2006) ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442\u2013452","journal-title":"Ann Rheum Dis"},{"key":"2700_CR4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","volume":"70","author":"J Braun","year":"2011","unstructured":"Braun J, van den Berg R, Baraliakos X et al (2011) 2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896\u2013904","journal-title":"Ann Rheum Dis"},{"key":"2700_CR5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.1780310905","volume":"31","author":"M Nissila","year":"1988","unstructured":"Nissila M, Lehtinen K, Leirisalo-Repo M, Luukkainen R, Mutru O, Yli-Kerttula U (1988) Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum 31:1111\u20131116","journal-title":"Arthritis Rheum"},{"key":"2700_CR6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/rheumatology\/32.8.729","volume":"32","author":"J Kirwan","year":"1993","unstructured":"Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H (1993) The course of established ankylosing spondylitis and the effects of sulphasalazine over 3\u00a0years. Br J Rheumatol 32:729\u2013733","journal-title":"Br J Rheumatol"},{"key":"2700_CR7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/ard.2006.052878","volume":"65","author":"J Braun","year":"2006","unstructured":"Braun J, Zochling J, Baraliakos X et al (2006) Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis 65:1147\u20131153","journal-title":"Ann Rheum Dis"},{"key":"2700_CR8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/030097400750002021","volume":"29","author":"PD Sampaio-Barros","year":"2000","unstructured":"Sampaio-Barros PD, Costallat LT, Bertolo MB, Neto JF, Samara AM (2000) Methotrexate in the treatment of ankylosing spondylitis. Scand J Rheumatol 29:160\u2013162","journal-title":"Scand J Rheumatol"},{"key":"2700_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s100670050027","volume":"19","author":"D Biasi","year":"2000","unstructured":"Biasi D, Carletto A, Caramaschi P, Pacor ML, Maleknia T, Bambara LM (2000) Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study. Clin Rheumatol 19:114\u2013117","journal-title":"Clin Rheumatol"},{"key":"2700_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/030097401753180318","volume":"30","author":"L Altan","year":"2001","unstructured":"Altan L, Bingol U, Karakoc Y, Aydiner S, Yurtkuran M, Yurtkuran M (2001) Clinical investigation of methotrexate in the treatment of ankylosing spondylitis. Scand J Rheumatol 30:255\u2013259","journal-title":"Scand J Rheumatol"},{"key":"2700_CR11","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/rheumatology\/41.11.1330","volume":"41","author":"B Roychowdhury","year":"2002","unstructured":"Roychowdhury B, Bintley-Bagot S, Bulgen DY, Thompson RN, Tunn EJ, Moots RJ (2002) Is methotrexate effective in ankylosing spondylitis? Rheumatology (Oxford) 41:1330\u20131332","journal-title":"Rheumatology (Oxford)"},{"key":"2700_CR12","first-page":"496","volume":"24","author":"O Kaipiainen-Seppanen","year":"1997","unstructured":"Kaipiainen-Seppanen O, Aho K, Heliovaara M (1997) Incidence and prevalence of ankylosing spondylitis in Finland. J Rheumatol 24:496\u2013499","journal-title":"J Rheumatol"},{"key":"2700_CR13","first-page":"94","volume":"27","author":"O Kaipiainen-Seppanen","year":"2000","unstructured":"Kaipiainen-Seppanen O, Aho K (2000) Incidence of chronic inflammatory joint diseases in Finland in 1995. J Rheumatol 27:94\u2013100","journal-title":"J Rheumatol"},{"key":"2700_CR14","doi-asserted-by":"crossref","first-page":"2188.e1","DOI":"10.1016\/j.ophtha.2009.04.020","volume":"116","author":"S Gangaputra","year":"2009","unstructured":"Gangaputra S, Newcomb CW, Liesegang TL et al (2009) Methotrexate for ocular inflammatory diseases. Ophthalmology 116:2188.e1\u20132198.e1","journal-title":"Ophthalmology"},{"key":"2700_CR15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780260210","volume":"26","author":"S Carette","year":"1983","unstructured":"Carette S, Graham D, Little H, Rubenstein J, Rosen P (1983) The natural disease course of ankylosing spondylitis. Arthritis Rheum 26:186\u2013190","journal-title":"Arthritis Rheum"},{"key":"2700_CR16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/36.7.766","volume":"36","author":"JT Gran","year":"1997","unstructured":"Gran JT, Skomsvoll JF (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36:766\u2013771","journal-title":"Br J Rheumatol"},{"key":"2700_CR17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/rheumatology\/28.5.410","volume":"28","author":"MJ Davis","year":"1989","unstructured":"Davis MJ, Dawes PT, Beswick E, Lewin IV, Stanworth DR (1989) Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin. Br J Rheumatol 28:410\u2013413","journal-title":"Br J Rheumatol"},{"key":"2700_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02208032","volume":"10","author":"HG Taylor","year":"1991","unstructured":"Taylor HG, Beswick EJ, Dawes PT (1991) Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment. Clin Rheumatol 10:43\u201348","journal-title":"Clin Rheumatol"},{"key":"2700_CR19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10067-008-0877-1","volume":"27","author":"H Bodur","year":"2008","unstructured":"Bodur H, Ataman S, Akbulut L et al (2008) Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 27:1119\u20131125","journal-title":"Clin Rheumatol"},{"key":"2700_CR20","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s10067-007-0574-5","volume":"26","author":"L Konttinen","year":"2007","unstructured":"Konttinen L, Tuompo R, Uusitalo T et al (2007) Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience. Clin Rheumatol 26:1693\u20131700","journal-title":"Clin Rheumatol"},{"key":"2700_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landewe R et al (2011) The assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25\u201331","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2700-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2700-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2700-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:35Z","timestamp":1559120255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2700-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,7]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2700-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,7]]}}}